Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Treasury Shares: 2021-2024

Historic Treasury Shares for Prime Medicine (PRME) over the last 4 years, with Dec 2024 value amounting to $3.5 million.

  • Prime Medicine's Treasury Shares changed negligibly% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $3.5 million for FY2024, which is 9.40% down from last year.
  • Latest data reveals that Prime Medicine reported Treasury Shares of $3.5 million as of FY2024, which was down 9.40% from $3.8 million recorded in FY2023.
  • In the past 5 years, Prime Medicine's Treasury Shares registered a high of $10.8 million during FY2021, and its lowest value of $3.5 million during FY2024.
  • Over the past 3 years, Prime Medicine's median Treasury Shares value was $3.8 million (recorded in 2023), while the average stood at $4.1 million.
  • Data for Prime Medicine's Treasury Shares shows a maximum YoY tumbled of 53.57% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Prime Medicine's Treasury Shares stood at $10.8 million in 2021, then tumbled by 53.57% to $5.0 million in 2022, then decreased by 23.57% to $3.8 million in 2023, then fell by 9.40% to $3.5 million in 2024.